During the past decade, National Hospital Organization Kinki-Chuo Chest Medical Center conducted 32 clinical trials. In the 10-year time frame, 32 clinical trials started and 13 clinical trials were completed, i.e. on average, 40.6% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 10 clinical trials were completed. i.e. 52.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "National Hospital Organization Kinki-Chuo Chest Medical Center" #1 sponsor was "Boehringer Ingelheim" with 12 trials, followed by "Hoffmann-La Roche" with 11 trials sponsored, "Chugai Pharmaceutical" with 2 trials sponsored, "Galapagos NV" with 2 trials sponsored and "Merck Sharp & Dohme LLC" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "National Hospital Organization Kinki-Chuo Chest Medical Center" #1 collaborator was "Japan Lung Cancer Society" with 2 trials as a collaborator, "Atea Pharmaceuticals, Inc." with 1 trials as a collaborator, "Boehringer Ingelheim" with 1 trials as a collaborator and "Ministry of Health, Labour and Welfare, Japan" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "National Hospital Organization Kinki-Chuo Chest Medical Center" are "Idiopathic Pulmonary Fibrosis" (11 trials), "Lung Diseases, Interstitial" (4 trials), "Non-Small Cell Lung Cancer" (3 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials) and "ALK-positive Non-small-cell Lung Cancer" (1 trials). Many other conditions were trialed in "National Hospital Organization Kinki-Chuo Chest Medical Center" in a lesser frequency.

Most popular intervention types in "National Hospital Organization Kinki-Chuo Chest Medical Center" are "Drug" (37 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (16 trials), "Carboplatin" (6 trials), "Nintedanib" (6 trials), "Pemetrexed" (5 trials) and "Atezolizumab" (4 trials). Other intervention names were less common.

The vast majority of trials in "National Hospital Organization Kinki-Chuo Chest Medical Center" are 40 trials for "All" genders.

Currently, there are NaN active trials in "National Hospital Organization Kinki-Chuo Chest Medical Center". undefined are not yet recruiting, 8 are recruiting, 6 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 22 completed trials in National Hospital Organization Kinki-Chuo Chest Medical Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in National Hospital Organization Kinki-Chuo Chest Medical Center, 2 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 28 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 0 trials that are defined as “Not Applicable".